& Monument Traders Alliance
Good day, 360!
Don’t forget to secure access to pro trader Nate Bear’s #1 Pick of the MONTH and track it with him LIVE for just $149/year (includes 365 day $MBG)! HAPPENING LIVE TODAY (Mon) @12pm EST. Be the best prepared trader on the Street!
FOCUS LIST🔎
SINT – Up over 75% in the pre-market after announcing stock repurchase program
NIVF- Up over 70% in pre after entering into a binding term sheet with White Lion Capital for $100 million equity line of credit, expandable to $500 million
HCWB- Up over 200% in pre after announcing license agreement for immunotherapeutic product candidate with WY Biotech
*sponsored by The Oxford Club
The NEXT Trillion Dollar Company?
This company just signed a MASSIVE deal with Apple.
It gets their AI tech in Apple’s iPhones and iMacs until 2040!
But it goes beyond that.
The company is getting its tech into products by Nvidia, Google, and Samsung too.
Its AI tech is so crucial…
Nvidia is actually buying up the stock too.
They’ve invested more in this one company than any other… nearly $150 million.
Is this stock the next Nvidia… which has gone up 81,700% over the last 20 years?
HOTLIST🔥
SINT – Up over 75% in the pre-market after announcing stock repurchase program
SINTX Technologies Inc. (SINT) is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications.
In the pre-market this morning, the company announced that its Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company’s outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares.
The repurchases will be conducted based on market conditions and other factors, reflecting SINTX’s confidence in its strategic direction and commitment to enhancing shareholder value.
Shares of SINT traded up over 75% in the pre-market in reaction to the news.
The $3.06 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $3.40, $3.60 and then the pre-market high at $3.80. Beyond that, $4.30, $4.90 and $5.50 come into play.
Below $3.06, targets to the downside are $3, $2.80, $2.63, $2.40 and then a gap fill at $2.04.
NIVF- Up over 70% in pre after entering into a binding term sheet with White Lion Capital for $100 million equity line of credit, expandable to $500 million
NewGenIvf Group Limited (NIVF) is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments.
In the pre-market this morning, the company announced that it has entered into a binding term sheet with White Lion Capital, LLC, a California-based institutional investor focused on high-growth, early-stage public companies, setting out the principal terms and conditions for a $100 million equity line of credit, expandable to $500 million.
Pursuant to the Term Sheet, NewGen will have the option, but not the obligation, to sell to White Lion up to $100.0 million in shares of common stock over an initial 36-month period, with the potential to increase to $300.0 million upon substantial M&A or merger activity, and further to $500.0 million after $250.0 million has been drawn. The transactions contemplated by the Term Sheet are subject to entry into definitive agreements, and are subject to certain conditions, including a registration statement being filed immediately upon execution of the definitive agreements.
Shares of NIVF traded up over 70% in the pre-market in reaction to the news.
The $1 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.18, $1.27 and then the pre-market high at $1.47. Beyond that, $1.58, $1.66, $2.27 and $3.28 come into play.
Below $1, targets to the downside are $0.85, $0.75 and then a gap fill at $0.6510.
*together with Monument Trader’s Alliance
Target Massive 100%+ Profit Surge Trades With Nate Bear… LIVE Every Week!
Join NOW before his next big trade on:
Monday Nov 18th @ 12PM EST
HCWB- Up over 200% in pre after announcing license agreement for immunotherapeutic product candidate with WY Biotech
HCW Biologics Inc. (HCWB) is a clinical-stage biopharmaceutical company that focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
In the pre-market this morning, the company announced that it and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies have entered into a worldwide exclusive license agreement to develop and commercialize one of HCWB’s product candidates generated with its new drug discovery platform for therapeutic use.
Key terms of the agreement include that WY Biotech has agreed to pay HCWB $7.0 million in an upfront payment, and HCWB is eligible to receive additional significant development milestone payments and double-digit royalties on future product sales.
In addition, HCWB will share a substantial portion of the proceeds from a future transaction(s) involving the molecule, if such a transaction occurs. HCWB also has a payment-free, milestone-free, and royalty-free option to recapture the development and commercialization rights of this molecule for the United States, Canada, Central America, and South America (Opt-in Territory) after the conclusion of the Phase 1 clinical trial.
WY Biotech is financially responsible for all costs associated with research and development, manufacturing, clinical development, regulatory approval, and commercialization for the molecule.
Shares of HCWB traded up over 200% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $1.32. Beyond that, $1.60, $1.93, $2.15 and $2.50 come into play.
Below $1.32, targets to the downside are $1, $0.85, $0.70, $0.60, $0.50, $0.40 and then a gap fill at $0.2946.
MARKET NEWS 📰
P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
